147 related articles for article (PubMed ID: 37161360)
1. Bleeding risk and mortality according to antithrombotic agents' exposure in cancer-related stroke patients: nationwide population-based cohort study in South Korea.
Choi BK; Lee JS; Kim HR; Kim HS; Jung YH; Park YR
BMC Neurol; 2023 May; 23(1):187. PubMed ID: 37161360
[TBL] [Abstract][Full Text] [Related]
2. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study.
Toyoda K; Yasaka M; Iwade K; Nagata K; Koretsune Y; Sakamoto T; Uchiyama S; Gotoh J; Nagao T; Yamamoto M; Takahashi JC; Minematsu K;
Stroke; 2008 Jun; 39(6):1740-5. PubMed ID: 18388341
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation.
McGrath ER; Kapral MK; Fang J; Eikelboom JW; Conghaile Aó; Canavan M; O'Donnell MJ;
Stroke; 2014 Dec; 45(12):3637-42. PubMed ID: 25378422
[TBL] [Abstract][Full Text] [Related]
4. Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis.
Martí-Fàbregas J; Camps-Renom P; Best JG; Ramos-Pachon A; Guasch-Jiménez M; Martinez-Domeño A; Guisado-Alonso D; Gómez-Ansón BM; Ambler G; Wilson D; Lee KJ; Lim JS; Bae HJ; Shiozawa M; Koga M; Toyoda K; Hennerici MG; Chabriat H; Jouvent E; Wong DYK; Mak H; Lau KK; Kim YD; Song TJ; Heo JH; Eppinger S; Gattringer T; Uysal E; Demirelli DS; Bornstein N; Ben Assayag E; Hallevi H; Molad JA; Nishihara M; Tanaka J; Hara H; Yakushiji Y; Coutts SB; Smith E; Polymeris AA; Wagner B; Seiffge D; Lyrer PA; Peters N; Engelter ST; Al-Shahi Salman R; Jäger HR; Lip GYH; Goeldlin M; Panos L; Karayiannis CC; Phan TG; Srikanth VK; Christ N; Gunkel S; Fluri F; Leung TW; Soo YOY; Chu W; Abrigo J; Barbato C; Browning S; Simister R; Mendyk AM; Bordet R; Hilal S; Gyanwali B; Chen C; Jung S; Necioglu Orken D; Werring D; Prats-Sanchez L;
Neurology; 2023 Mar; 100(12):e1267-e1281. PubMed ID: 36535778
[TBL] [Abstract][Full Text] [Related]
5. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
[TBL] [Abstract][Full Text] [Related]
6. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.
Staerk L; Lip GY; Olesen JB; Fosbøl EL; Pallisgaard JL; Bonde AN; Gundlund A; Lindhardt TB; Hansen ML; Torp-Pedersen C; Gislason GH
BMJ; 2015 Nov; 351():h5876. PubMed ID: 26572685
[TBL] [Abstract][Full Text] [Related]
7. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet agents and anticoagulants for hypertension.
Shantsila E; Kozieł-Siołkowska M; Lip GY
Cochrane Database Syst Rev; 2022 Jul; 7():CD003186. PubMed ID: 35900898
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
11. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.
Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E
JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049
[TBL] [Abstract][Full Text] [Related]
12. Association of Ischemic and Bleeding Events With Mortality Among Patients in Sweden With Recent Acute Myocardial Infarction Receiving Antithrombotic Therapy.
Simonsson M; Alfredsson J; Szummer K; Jernberg T; Ueda P
JAMA Netw Open; 2022 Aug; 5(8):e2220030. PubMed ID: 36036452
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke.
Chang KW; Xian Y; Zhao X; Mi X; Matsouaka R; Schwamm LH; Shah S; Lytle BL; Smith EE; Bhatt DL; Fonarow GC; Hsu JC
Int J Cardiol; 2020 Dec; 321():88-94. PubMed ID: 32805327
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Medication and the Risk of Vitreous Hemorrhage in Atrial Fibrillation: Korean National Health Insurance Service National Cohort.
Kim KE; Yang PS; Jang E; Kim S; Joung B
Yonsei Med J; 2019 Jan; 60(1):65-72. PubMed ID: 30554492
[TBL] [Abstract][Full Text] [Related]
15. Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study.
Chen PC; Lip GY; Yeh G; Lin HJ; Chien KL
PLoS One; 2015; 10(4):e0125257. PubMed ID: 25923742
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiplatelet persistence on long-term mortality and predictors of non-persistence in ischemic stroke patients 75 years and older: a nationwide cohort study.
Kim SJ; Kwon OD; Choi HC; Lee EJ; Cho B
BMC Geriatr; 2021 Apr; 21(1):232. PubMed ID: 33827445
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
[TBL] [Abstract][Full Text] [Related]
18. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database.
Giner-Soriano M; Roso-Llorach A; Vedia Urgell C; Castells X; Capellà D; Ferreira-González I; Elorza-Ricart JM; Casajuana M; Troncoso Mariño A; Diògene E; Bolíbar B; Violan C; Morros R
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):97-107. PubMed ID: 27868275
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome.
Lv WH; Dong JZ; Du X; Hu R; He L; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Chen X; Cui YK; Tang RB; Ma CS
J Thromb Thrombolysis; 2022 May; 53(4):868-877. PubMed ID: 34677727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]